Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Five-year microevolution of a multidrug-resistant Mycobacterium tuberculosis strain within a patient with inadequate compliance to treatment

Fig. 3

Frequency of drug-resistance conferring mutations along with treatment history. TERI: terizidone, PAS: para-aminosalicylic acid, OFX: ofloxacin, KAN: kanamycin, PZA: pyrazinamide, Cs: cycloserine, LNZ: linezolid, MXF: moxifloxacin, MXF-hd: moxifloxacin high dose, IC: imipenem-clavulanate, MC: meropenem-clavulanate AMK: amikacin. Continue-line: fixed mutations, dashed lines: non fixed mutations

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us